| 摘要 |
1. A composition, in one or more parts, for the treatment of gastric and/or duodenal H. pylori infections, the composition including effective amounts of: (a) a proton pump inhibitor in a systemically available dosage form; (b) a mucolytic preparation; (c) a proton pump inhibitor in a gastrically available dosage form; and (d) a fatty acid and/or monoglyceride.
|
